These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 28882176

  • 41. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.
    Stokes MG, Titball RW, Neeson BN, Galen JE, Walker NJ, Stagg AJ, Jenner DC, Thwaite JE, Nataro JP, Baillie LW, Atkins HS.
    Infect Immun; 2007 Apr; 75(4):1827-34. PubMed ID: 17145938
    [Abstract] [Full Text] [Related]

  • 42. BclA and toxin antigens augment each other to protect NMRI mice from lethal Bacillus anthracis challenge.
    Köhler SM, Baillie LW, Beyer W.
    Vaccine; 2015 Jun 04; 33(24):2771-7. PubMed ID: 25917676
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Recombinant exosporium protein BclA of Bacillus anthracis is effective as a booster for mice primed with suboptimal amounts of protective antigen.
    Brahmbhatt TN, Darnell SC, Carvalho HM, Sanz P, Kang TJ, Bull RL, Rasmussen SB, Cross AS, O'Brien AD.
    Infect Immun; 2007 Nov 04; 75(11):5240-7. PubMed ID: 17785478
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine.
    Little SF, Ivins BE, Fellows PF, Pitt ML, Norris SL, Andrews GP.
    Vaccine; 2004 Jan 02; 22(3-4):422-30. PubMed ID: 14670324
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Evaluation of Bacillus anthracis extractable antigen for testing anthrax immunity.
    Shlyakhov E, Shoenfeld Y, Gilburd B, Rubinstein E.
    Clin Microbiol Infect; 2004 May 02; 10(5):421-4. PubMed ID: 15113319
    [Abstract] [Full Text] [Related]

  • 50. Correlation between anthrax lethal toxin neutralizing antibody levels and survival in guinea pigs and nonhuman primates vaccinated with the AV7909 anthrax vaccine candidate.
    Savransky V, Shearer JD, Gainey MR, Sanford DC, Sivko GS, Stark GV, Li N, Ionin B, Lacy MJ, Skiadopoulos MH.
    Vaccine; 2017 Sep 05; 35(37):4952-4959. PubMed ID: 28774566
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.
    Cote CK, Rossi CA, Kang AS, Morrow PR, Lee JS, Welkos SL.
    Microb Pathog; 2005 Sep 05; 38(5-6):209-25. PubMed ID: 15925272
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Recombinant full-length Bacillus Anthracis protective antigen and its 63 kDa form elicits protective response in formulation with addavax.
    Sharma S, Bahl V, Srivastava G, Shamim R, Bhatnagar R, Gaur D.
    Front Immunol; 2022 Sep 05; 13():1075662. PubMed ID: 36713362
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.